ABSTRACT:
Human Papillomavirus (HPV) infection is the most common sexually transmitted infection worldwide and a necessary cause of cervical cancer. Adolescence represents a critical window for HPV vaccination, as immunization before sexual debut provides maximal protection against oncogenic HPV strains. This review synthesizes evidence on the epidemiology of HPV infection in adolescent girls, immunological justification for early vaccination, vaccine types, efficacy, safety, global and India-specific coverage trends, barriers to uptake, and public health strategies to enhance vaccination rates. The evidence overwhelmingly supports HPV vaccination among adolescent girls as a safe, effective, and cost-effective intervention for reducing cervical cancer burden and improving long-term women’s health outcomes.
Cite this article:
Preeti Chouhan. Human Papillomavirus (HPV) Vaccination among Adolescent Girls: Implications for Cervical Cancer Prevention and Women’s Health. Asian Journal of Nursing Education and Research. 2026;16(2):137-9. doi: 10.52711/2349-2996.2026.00028
Cite(Electronic):
Preeti Chouhan. Human Papillomavirus (HPV) Vaccination among Adolescent Girls: Implications for Cervical Cancer Prevention and Women’s Health. Asian Journal of Nursing Education and Research. 2026;16(2):137-9. doi: 10.52711/2349-2996.2026.00028 Available on: https://www.ajner.com/AbstractView.aspx?PID=2026-16-2-13
15. REFERENCES:
1. Harper, D. M., et al. (2025). Impact of human papillomavirus vaccines in the reduction of cervical cancer precursors and related outcomes: updated global evidence. PMC Article.
2. Islam, M. R. (2025). Recent advances in human papillomavirus vaccines and future directions. Journal of Clinical Virology.
3. Brotherton, J. M. L., et al. (2025). Global status of HPV vaccination two decades in: population impact and cervical cancer trends. International Journal of Public Health.
4. Ilic, I. (2025). Human papillomavirus vaccination coverage estimates among the primary target cohort (9–14 year old girls) in the world (2010–2024). Vaccines.
5. World Health Organization. (2025). Global HPV vaccination programs and coverage rates: A systematic review. PubMed.
6. Tippins, A., Mutamba, G., Boyd, E. M., Coy, K. C., and Kriss, J. L. (2024). Human papillomavirus vaccination coverage among adolescent girls aged 13–17 years — U.S. Affiliated Pacific Islands (2013–2023). MMWR Weekly.
7. Dessy, H., et al. (2026). Maximizing impact: lessons from early HPV vaccination for long term cervical cancer prevention. Journal of Public Health.
8. Harper, D. M., et al. Impact of Human Papillomavirus Vaccines in the Reduction of Cervical Cancer Precursors and Related Outcomes: Updated Global Evidence. PMC, 2025.
9. Islam, M. R. Recent Advances in Human Papillomavirus Vaccines and Future Directions. Journal of Clinical Virology. 2025.
10. Brotherton, J. M. L., et al. Global Status of HPV Vaccination Two Decades In: Population Impact and Cervical Cancer Trends. International Journal of Public Health. 2025.
11. Ilic, I. Human Papillomavirus Vaccination Coverage Estimates Among the Primary Target Cohort (9–14 Year Old Girls) in the World (2010–2024). Vaccines, 2025.
12. World Health Organization. Global HPV Vaccination Programs and Coverage Rates: A Systematic Review. PubMed. 2025.
13. Tippins, A., et al. Human Papillomavirus Vaccination Coverage Among Adolescent Girls Aged 13–17 Years — U.S. Affiliated Pacific Islands, 2013–2023. MMWR Weekly. 2024.
14. Dessy, H., et al. Maximizing Impact: Lessons From Early HPV Vaccination for Long Term Cervical Cancer Prevention. Journal of Public Health, 2026.